Daily Data as of 5/26/2022
|Closing Market Price||$20.63|
|Common Shares Outstanding||41,356,058|
|52 Week Average Premium/Discount||-2.67%|
|52 Week High/Low Market Price||$|
|52 Week High/Low Market NAV||$|
|Current Distribution Rate||6.15%|
|Monthly Dividend Per Share||$0.1125|
|Ex-Dividend Date||April 20, 2022|
|Payable Date||April 29, 2022|
Monthly dividend per share annualized and excise distribution; divided by the April 29, 2022 market price per share. The Fund’s April 2022 distributions were comprised of net investment income, long-term capital gains and short-term capital gains. The distribution rate alone is not indicative of Fund performance. To the extent that any portion of the current distributions were estimated to be sourced from something other than income, such as return of capital, the source would have been disclosed in a Section 19(a) Notice located under the “Investor Information” section of the Fund’s website. Please note that the distribution classifications are preliminary and certain distributions may be re-classified at year end. Please refer to year-end tax documents for the final classifications of the Fund’s distributions for a given year.
Tekla Healthcare Opportunities Fund ("THQ") is a non-diversified closed-end fund traded on the New York Stock Exchange under the ticker THQ. THQ invests primarily in the healthcare industry. The Fund's objective is to seek current income and long-term capital appreciation through investing in companies engaged in the healthcare industry, including equity securities, debt securities and pooled investment vehicles.